Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trialHuijie Bian, Ye Zhang, Zhaowei Gao et al.|Signal Transduction and Targeted Therapy|2021Cited by 66
Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19Zhifeng Huang, Nanshan Zhong, Huimin Huang et al.|Clinical & Experimental Immunology|2020Cited by 41